Biogen Future Growth
Future criteria checks 3/6
Biogen is forecast to grow earnings and revenue by 17.1% and 1.6% per annum respectively. EPS is expected to grow by 18% per annum. Return on equity is forecast to be 14.4% in 3 years.
Key information
17.1%
Earnings growth rate
17.9%
EPS growth rate
Biotechs earnings growth | 34.8% |
Revenue growth rate | 1.5% |
Future return on equity | 14.5% |
Analyst coverage | Good |
Last updated | 11 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 9,791 | 2,467 | 2,772 | 3,086 | 24 |
12/31/2025 | 9,587 | 2,148 | 2,725 | 2,964 | 30 |
12/31/2024 | 9,631 | 1,899 | 1,952 | 2,889 | 30 |
6/30/2024 | 9,672 | 1,159 | 1,571 | 1,784 | N/A |
3/31/2024 | 9,663 | 1,167 | 1,284 | 1,645 | N/A |
12/31/2023 | 9,836 | 1,161 | 1,236 | 1,547 | N/A |
9/30/2023 | 9,993 | 1,462 | 1,026 | 1,360 | N/A |
6/30/2023 | 9,972 | 2,665 | 1,123 | 1,428 | N/A |
3/31/2023 | 10,105 | 3,131 | 1,421 | 1,678 | N/A |
12/31/2022 | 10,173 | 3,047 | 1,141 | 1,384 | N/A |
9/30/2022 | 10,363 | 2,865 | 2,173 | 2,398 | N/A |
6/30/2022 | 10,634 | 2,059 | 2,315 | 2,542 | N/A |
3/31/2022 | 10,820 | 1,450 | 2,773 | 3,033 | N/A |
12/31/2021 | 10,982 | 1,556 | 3,345 | 3,640 | N/A |
9/30/2021 | 11,101 | 1,546 | 2,107 | 2,435 | N/A |
6/30/2021 | 11,698 | 1,918 | 2,461 | 2,810 | N/A |
3/31/2021 | 12,604 | 3,012 | 3,149 | 3,532 | N/A |
12/31/2020 | 13,445 | 4,001 | 3,678 | 4,230 | N/A |
9/30/2020 | 14,263 | 5,082 | 5,841 | 6,557 | N/A |
6/30/2020 | 14,487 | 5,927 | 6,349 | 7,071 | N/A |
3/31/2020 | 14,422 | 5,879 | 6,282 | 7,086 | N/A |
12/31/2019 | 14,378 | 5,889 | 6,409 | 7,079 | N/A |
9/30/2019 | 14,233 | 5,396 | 6,384 | 7,014 | N/A |
6/30/2019 | 14,072 | 5,294 | 6,324 | 7,055 | N/A |
3/31/2019 | 13,812 | 4,667 | 5,382 | 6,190 | N/A |
12/31/2018 | 13,453 | 4,431 | 5,302 | 6,188 | N/A |
9/30/2018 | 13,234 | 3,187 | 4,855 | 5,811 | N/A |
6/30/2018 | 12,872 | 2,968 | 4,659 | 5,703 | N/A |
3/31/2018 | 12,594 | 2,964 | N/A | 5,773 | N/A |
12/31/2017 | 12,274 | 2,539 | N/A | 4,551 | N/A |
9/30/2017 | 11,839 | 3,486 | N/A | 4,615 | N/A |
6/30/2017 | 11,717 | 3,293 | N/A | 3,978 | N/A |
3/31/2017 | 11,533 | 3,480 | N/A | 3,807 | N/A |
12/31/2016 | 11,449 | 3,703 | N/A | 4,587 | N/A |
9/30/2016 | 11,416 | 3,885 | N/A | 4,046 | N/A |
6/30/2016 | 11,238 | 3,818 | N/A | 3,950 | N/A |
3/31/2016 | 10,936 | 3,695 | N/A | 3,999 | N/A |
12/31/2015 | 10,764 | 3,547 | N/A | 3,919 | N/A |
9/30/2015 | 10,565 | 3,599 | N/A | 3,609 | N/A |
6/30/2015 | 10,299 | 3,490 | N/A | 3,627 | N/A |
3/31/2015 | 10,128 | 3,277 | N/A | 3,570 | N/A |
12/31/2014 | 9,703 | 2,935 | N/A | 2,942 | N/A |
9/30/2014 | 9,028 | 2,509 | N/A | 2,878 | N/A |
6/30/2014 | 8,345 | 2,139 | N/A | 2,636 | N/A |
3/31/2014 | 7,647 | 1,916 | N/A | 2,271 | N/A |
12/31/2013 | 6,932 | 1,862 | N/A | 2,345 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BIIB's forecast earnings growth (17.1% per year) is above the savings rate (1.2%).
Earnings vs Market: BIIB's earnings (17.1% per year) are forecast to grow faster than the Austrian market (7% per year).
High Growth Earnings: BIIB's earnings are forecast to grow, but not significantly.
Revenue vs Market: BIIB's revenue (1.6% per year) is forecast to grow faster than the Austrian market (-0.4% per year).
High Growth Revenue: BIIB's revenue (1.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BIIB's Return on Equity is forecast to be low in 3 years time (14.4%).